IHH Healthcare FY2025 net profit falls 21% to $682.67m

The decrease is due to unrealised currency translation losses from a stronger ringgit.

IHH Healthcare reported a profit after tax and minority interests (PATMI) of $682.67m (RM2.1b) for FY2025, down 21% year-on-year.

The decrease is attributed to unrealised currency translation losses from a stronger ringgit, the group said in a press release.

Revenue rose 6% to $8.36b (RM25.7b), whilst EBITDA increased 3% to $1.82b (RM5.6b).

On a constant currency basis, core PATMI (excluding exceptional items) increased 3% to $747.77m (RM2.3b), whilst core revenue grew 18% to $8.52b (RM26.2b).

The board approved a dividend of 3.5 cents (10.5 sen) per share for FY2025, up from 3.3 cents (10 sen) in FY2024.

$1 = RM3.08.

Follow the link for more news on

IHH Healthcare

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia